Capsule endoscopy Market Projected to Grow Ecstatically By 2030; Asserts MRFR Unleashing Industry Forecast

Global Capsule Endoscopy Market is predicted to reach USD 1.6 billion at a CAGR of 8.40% during the forecast period:

Market Research Future (MRFR) has published a cooked research report on the “Global Capsule Endoscopy Market” that contains information from 2023 to 2030. The Global Capsule Endoscopy Market is estimated to register a CAGR of 8.40% during the forecast period of 2023 to 2032.

Market Highlights

Global Capsule Endoscopy Market is accounted to register a CAGR of 8.40% during the forecast period and is estimated to reach USD 1.6 Billion by 2032.

Capsule endoscopy is a non-invasive medical procedure used to visualize and diagnose conditions of the gastrointestinal (GI) tract. It involves the ingestion of a small, disposable capsule containing a camera, light source, and transmitter. As the capsule travels through the digestive system, it captures high-resolution images of the esophagus, stomach, small intestine, and sometimes the colon. These images are transmitted wirelessly to a recorder worn by the patient, and subsequently, the healthcare professional analyzes the images to identify abnormalities such as bleeding, ulcers, polyps, tumors, or inflammatory bowel disease. Capsule endoscopy offers a less invasive alternative to traditional endoscopic procedures, providing comprehensive visualization of the GI tract, especially in areas that are difficult to reach with conventional endoscopes.

Key Players: MRFR recognizes the following companies as the key players in the Global Capsule Endoscopy Market— RF System Lab, AccuRead Endoscopy Inc., Boston Scientific Corporation, Northside Gastroenterology Endoscopy Center, LLC, Chongqing Jinshan Science & Technology Co., Interscope Inc., and Given Imaging Ltd.

Segment Analysis

The Global Capsule Endoscopy Market has been segmented based on Product, Application, and End User.

Based on the Product, the market is segmented into Capsule Endoscopes, {Small Bowel, Esophageal, and Colon} and Systems. The Capsule Endoscopes category dominates the Capsule Endoscopy market due to its technological advancements, improved patient comfort, and ability to provide comprehensive visualization of the gastrointestinal tract.

Based on the Application, the market is segmented into OGIB (Obscure GI Tract Bleeding), Crohn’s Disease, Small Intestine Tumor, And Others. The OGIB (Obscure GI Tract Bleeding) category dominates the Capsule Endoscopy market due to its high diagnostic accuracy, minimally invasive nature, and effectiveness in identifying the source of bleeding in the gastrointestinal tract.

Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers, And Others. The Hospitals category dominates the Capsule Endoscopy market due to its widespread adoption, advanced infrastructure, and the availability of skilled medical professionals to perform and interpret capsule endoscopy procedures.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of: Capsule Endoscopy Market Research Report

Regional Analysis

The Global Capsule Endoscopy Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Global Capsule Endoscopy Market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The Global Capsule Endoscopy Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World's Global Capsule Endoscopy Market comprises of Middle East, Africa, and Latin America.

In 2021, North America witnessed a significant market share due to the increasing preference for minimally invasive screening methods and the adoption of technologically advanced products and systems. Additionally, Canada's high incidence rates of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, contribute to the region's prominence.

Asia-Pacific emerged as the fastest-growing region in 2021, driven by strong demand for capsule-based endoscopic technologies for screening procedures. Factors supporting this growth include improving healthcare infrastructure and a rising geriatric population. Furthermore, the presence of major players in the region and the consistent receipt of FDA approvals are additional factors fostering market expansion.

Key Findings of the Study

• North America commanded a significant market share due to the increasing preference for minimally invasive screening methods and the adoption of technologically advanced products and systems. Furthermore, Canada's high incidence rates of inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, contribute to the region's prominence in the market.


• Based on the Product, the Market has been segmented into Capsule Endoscopes holding the largest market in 2022.


• RF System Lab, AccuRead Endoscopy Inc., Boston Scientific Corporation, Northside Gastroenterology Endoscopy Center, LLC, Chongqing Jinshan Science & Technology Co., Interscope Inc., and Given Imaging Ltd.